Underwriting
Distracted Walking: Injuries Soar For Pedestrians On Phones
More than 1,500 pedestrians were estimated to be treated in emergency rooms in 2010 for injuries related to using a cell phone while walking, according to a new nationwide study. The number of such ...
Analysis: Optimism Fading, Brazil Protests Put Leaders On Alert
When more than 200,000 protesters took to the streets across Brazil on Monday night, they demanded a dizzying array of improvements—from halting the fast rise of prices to cleaning up government ...
Unrest In Turkey Highlights Terror Coverage Gaps, Willis Exec Says
With acts of terrorism defined in different ways under standalone terrorism insurance policies, insureds could find themselves without coverage in situations more akin to political violence than ...
Cyber Disclosure To SEC Not Universal; Even Insurer Fails To Report: Willis
A majority of the U.S. listed Fortune 500 firms are following the U.S. Securities and Exchange Guidelines by providing some level of disclosure regarding cyber exposures, but disclosure is not ...
Dark Clouds Forming; Data Security Hurricanes Ahead For Cyber Insurers
Data security and privacy (cyber liability) insurance has become one of the hottest topics for the insurance industry and an area of growth for an industry emerging from a soft market. While data and ...
IPO-Seeking China Companies Pay More to Avoid Boards Going Naked
Stephen Markscheid holds one of the riskiest jobs in the world—or so say directors and officers liability insurers. The 59-year-old former banker, a Mandarin-speaking American, sits on the boards ...
White House Threatens To Veto Farm Bill
The White House threatened to veto a five-year farm bill on Thursday because of "unacceptable deep cuts" in food stamps for the poor that could increase hunger across America. In a statement, the ...
Supreme Court Says FTC Can Sue Over Deals That Delay Generic Drug Sales
The U.S. Supreme Court ruled on Monday regulators can challenge deals between brand-name drug companies and generic rivals that delay cheaper medicines from going on sale, which regulators say ...